Public preferences for health states with schizophrenia and a mapping function to estimate utilities from positive and negative symptom scale scores

Schizophrenia Research

Volumn 71, Issue 1, 2004, Pages 155-165

  Lenert, Leslie A ^a,b,f   Sturley, Ann P ^c   Rapaport, Mark H ^c,d   Chavez, Shannon ^a   Mohr, Penny E ^e   Rupnow, Marcia ^e  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e Proj HOPE Center for Health Affairs   (United States)

^f Hlth Serv Research and Development   (United States)

Author keywords

Antipsychotic medication adverse effects; Computers; Economic analyses; Internet; Quality of life; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

AGE DISTRIBUTION; AKATHISIA; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ETHNOLOGY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; OBESITY; ORTHOSTATIC HYPOTENSION; PARKINSONISM; PRIORITY JOURNAL; SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT; TARDIVE DYSKINESIA; VIDEORECORDING; VISUAL ANALOG SCALE;

ANTIPSYCHOTIC AGENTS; ANXIETY; CHOICE BEHAVIOR; COGNITION DISORDERS; DEPRESSION; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; VIDEOTAPE RECORDING;

EID: 4444276242     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2003.10.010     Document Type: Article

References (25)

1. Brazier J., Roberts J., Deverill M. The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 21(2):2002;271-292
2. Devlin N.J., Hansen P., Kind P., Williams A. Logical inconsistencies in survey respondents' health state valuations - a methodological challenge for estimating social tariffs. Health Econ. 12(7):2003;529-544
3. Gold M., Patrick D., Torrance G., Fryback D., Hadorn D., Kamlet M., Daniels N., Weinstein M. Cost-effectiveness in Health and Medicine. 1996;Oxford Univ. Press, New York
4. Lee T.T., Ziegler J.K., Sommi R., Sugar C., Mahmoud R., Lenert L.A. Comparison of preferences for health outcomes in schizophrenia among stakeholder groups. J. Psychiatr. Res. 34(3):2000;201-210
5. Lenert L., Kaplan R.M. Validity and interpretation of preference-based measures of health-related quality of life [see comments]. Med. Care. 38(9 Suppl.):2000;II138-II150
6. Lenert L.A., Sturley A.E. Use of the internet to study the utility values of the public. Proc.-AMIA Symp. 2002;440-444
7. Lenert L.A., Treadwell J.R. Effects on preferences of violations of procedural invariance [in process citation]. Med. Decis. Mak. 19(4):1999;473-481
8. Lenert L.A., Morss S., Goldstein M.K., Bergen M.R., Faustman W.O., Garber A.M. Measurement of the validity of utility elicitations performed by computerized interview. Med. Care. 35(9):1997;915-920
9. Lenert L.A., Cher D.J., Goldstein M.K., Bergen M.R., Garber A. The effect of search procedures on utility elicitations. Med. Decis. Mak. 18(1):1998;76-83
10. Lenert L.A., Sherbourne C.D., Sugar C., Wells K.B. Estimation of utilities for the effects of depression from the SF-12. Med. Care. 38(7):2000;763-770
11. Lenert L.A., Ziegler J., Lee T., Sommi R., Mahmoud R. Differences in health values among patients, family members, and providers for outcomes in schizophrenia. Med. Care. 38(10):2000;1011-1021
12. Lenert L.A., Sturley A.E., Rupnow M. Toward improved methods for measurement of utility: automated repair of errors in utility elicitations. Med. Decis. Mak. 23(1):2003;1-9
13. Lin A., Lenert L.A., Hlatky M.A., McDonald K.M., Olshen R.A., Hornberger J. Clustering and the design of preference - assessment surveys in healthcare [in process citation]. Health Serv. Res. 34(5 Pt. 1):1999;1033-1045
14. Mahmoud R., Engelhart L., Ollendorf D., Oster G. The Risperidone Outcomes Study of Effectiveness (ROSE): a model for evaluating treatment strategies in typical psychiatric practice. J. Clin. Psychiatry. 60(Suppl. 3):1999;42-47. (discussion 48)
15. Marder S.R., Davis J.M., Chouinard G. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials [published erratum appears in J. Clin. Psychiatry 1998 Apr;59(4):200]. J. Clin. Psychiatry. 58(12):1997;538-546
16. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., Bourgeois M., Chouinard G., Islam M.Z., Kane J., Krishnan R., Lindenmayer J.P., Potkin S. Clozapine treatment for suicidality in schizophrenia: international suicide prevention trial (InterSePT). Arch. Gen. Psychiatry. 60(1):2003;82-91
17. Mohr P.E., Chang M., Claxton E., Corley R.R., Feldman J.J., Hargreaves W.A., Lehman A.F., Lenert L.A., Mahmoud R., Marder S.R., Neumann P.J. Capturing the Heterogeneity of Schizophrenia Disease States. Schizophrenia Research. 2003
18. Nichol M.B., Sengupta N., Globe D.R. Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36. Med. Decis. Mak. 21(2):2001;105-112
19. Pyne J.M., Sullivan G., Kaplan R., Williams D.K. Comparing the sensitivity of generic effectiveness measures with symptom improvement in persons with schizophrenia. Med. Care. 41(2):2003;208-217
20. Revicki D.A., Shakespeare A., Kind P. Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists. Int. Clin. Psychopharmacol. 11(2):1996;101-108
21. Stinnett A.A., Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med. Decis. Mak. 18(2 Suppl.):1998;S68-S80
22. Sugar C.A., Sturm R., Lee T.T., Sherbourne C.D., Olshen R.A., Wells K.B., Lenert L.A. Empirically defined health states for depression from the SF-12. Health Serv. Res. 33(4 Pt. 1):1998;911-928
23. Tengs T.O., Wallace A. One thousand health-related quality-of-life estimates. Med. Care. 38(6):2000;583-637
24. United States. National Telecommunications and Information Administration Falling Through the Net [IV]: Toward Digital Inclusion. 2000;U.S. Dept. of Commerce National Telecommunications and Information Administration, Washington, DC
25. White L., Harvey P.D., Opler L., Lindenmayer J.P. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS study group. Psychopathology. 30(5):1997;263-274